News
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Eli Lilly, virtually alone among its large-cap pharma peers, has been having an excellent year. The stock is up by a ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
The Louisiana Children's Museum (LCM) has announced a $2.5 million grant from Lilly Endowment Inc. to launch a groundbreaking ...
The meeting comes at a critical time as many U.S. businesses remain cautious, waiting for clarity on trade policies.
U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.
The (Santa Rosa) Press Democrat: Napa County’s $133 Million Jail To Open This Summer, With Shift Toward Rehabilitation, Mental Health Support Napa County’s long-anticipated new jail is slated ...
Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost ...
Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need ...
The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...
The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...
Adding nbUVB phototherapy to oral ritlecitinib improves facial and total body repigmentation in patients with nonsegmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results